SCHEMBL5041302

SCHEMBL5041302

Cc1ccc([C@@H](N)CC(=O)O)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
KMT2A Q03164 3/20 0.40
FFAR1 O14842 4/20 0.39
P2RX7 Q99572 3/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CYP2C9 P11712 3/20 0.37
MEN1 O00255 2/20 0.37
CYP2D6 P10635 2/20 0.37
CYP2C19 P33261 2/20 0.37
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
GABBR2 O75899 3/20 0.36
GABBR1 Q9UBS5 3/20 0.36
LMNA P02545 2/20 0.36
CYP3A4 P08684 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
NFKB1 P19838 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041305 1.00 SMN1; SMN2 (0.41) SMN1; SMN2TSHRKMT2AFFAR1P2RX7
SCHEMBL27552110 0.83 MAPT (0.40) SMN1; SMN2P2RX7HDAC1HDAC6LMNA
SCHEMBL10349460 0.81 TSHR (0.42) SMN1; SMN2TSHRFFAR1P2RX7HDAC1
SCHEMBL20140862 0.81 KMT2A (0.40) SMN1; SMN2KMT2AFFAR1P2RX7CYP2C9
SCHEMBL7747584 0.80 NAPRT (0.44) SMN1; SMN2TSHRKMT2AFFAR1CYP2C9
SCHEMBL12463784 0.80 NNMT (0.47) SMN1; SMN2KMT2AFFAR1MEN1ITGB3
SCHEMBL4475092 0.80 NNMT (0.47) SMN1; SMN2KMT2AFFAR1MEN1ITGB3
SCHEMBL3727872 0.80 NNMT (0.47) SMN1; SMN2KMT2AFFAR1MEN1ITGB3
SCHEMBL20184239 0.79 ADRA2A (0.39) SMN1; SMN2TSHRKMT2AP2RX7HDAC1
SCHEMBL2760888 0.79 ADRA2A (0.39) SMN1; SMN2TSHRKMT2AP2RX7HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1988078-B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders ORTHO MCNEIL PHARM INC (US) 2012-10-17 EP disclosed
EP-1988078-A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders Ortho-McNeil Pharmaceutical, Inc. (US) 2008-11-05 EP disclosed
EP-0923555-B1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO MCNEIL PHARM INC (US) 2005-06-15 EP disclosed
EP-1184374-A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders ORTHO PHARMACEUTICAL CORPORATION (US) 2002-03-06 EP disclosed
US-6069254-A Carboxamide derivatives of piperidine for the treatment of thrombosis disorders ORTHO PHARMACEUTICAL CORP. (US) 2000-05-30 US disclosed
EP-0923555-A1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1999-06-23 EP disclosed
WO-1997041102-A1 CARBOXAMIDE DERIVATIVES OF PYRROLIDINE, PIPERIDINE AND HEXAHYDROAZEPINE FOR THE TREATMENT OF THROMBOSIS DISORDERS ORTHO PHARMACEUTICAL CORPORATION (US) 1997-11-06 WO disclosed